Fetal neuroinflammation and prenatal stress (PS) may contribute to lifelong neurological disabilities. Astrocytes and microglia play a pivotal role, but the mechanisms are poorly understood. Here, we test the hypothesis that via gene-environment interactions, fetal neuroinflammation and PS may reprogram glial immunometabolic phenotypes which impact neurodevelopment and neurobehavior. This glial-neuronal interplay increases the risk for clinical manifestation of autism spectrum disorder (ASD) in at-risk children. Drawing on genomic data from the recently published series of ovine and rodent glial transcriptome analyses with fetuses exposed to neuroinflammation or PS, we conducted a secondary analysis against the Simons Foundation Autism Research Initiative (SFARI) Gene database. We confirmed 21 gene hits. Using unsupervised statistical network analysis, we then identified six clusters of probable protein-protein interactions mapping onto the immunometabolic and stress response networks and epigenetic memory. These findings support our hypothesis. We discuss the implications for ASD etiology, early detection, and novel therapeutic approaches.
A body of preclinical and epidemiological evidence shows that in utero exposure to infection or stress results in altered neurodevelopmental trajectories including psychiatric conditions such as autism spectrum disorder (ASD). (1) (2, 3) However, the mechanisms explaining the individual risk and framework for early detection have remained elusive. To explore the potential connections between fetal neuroinflammation, prenatal stress (PS) and ASD, and to generate new hypotheses on the microglial and astrocytes' contribution, the key players of brain inflammation, we tested for the presence of disruptive mutations to genes involved in pathways associated with stress or inflammatory responses in a large sample of children with ASD. We based this method on the notion of a multi-species approach to uncovering the etiology of neurodevelopmental disorders. (2) Combining biomarkers derived from observations in multiple species such as rodent, ovine and human in the present case, should increase the likelihood of identifying translationally valid disease etiology.
Based on the studies in the above-mentioned multiple species, we identified genes associated with inflammatory, stress and metabolic phenotype of microglia and astrocytes (Table 1) . We included genes involved in energy homeostasis based on the observations linking neuroimmune and metabolic memory signatures in fetal microglia exposed to LPS and the larger emerging gestalt of physiological stress response in immunometabolism, in particular by astrocytes. (4,5) Based on our observations in fetal microglia (6, 7) , the simplistic hypothesis is that exposure to endotoxin or chronic stress augments energy conservation -driving pathways and the α7 nicotinic acetylcholine receptor α7nAChR agonism reduces that response. Such gene-environment adaptations should be reflected in changes of epigenetic memory mediated by HDAC/HAT networks involved in microglial memory of inflammation. (6) We included the iron homeostasis genes based on the recently postulated interaction between this signaling network and the α7nAChR modulation of immunometabolic phenotype of fetal microglia. (7) We included the complement pathway genes expressed in microglia and known to be modulated by neuroinflammation in microglia and to play an important role in neurodevelopmental synaptic pruning. (7, 8) Assuming that in utero inflammation or stress increase risk for ASD, we hypothesized to identify some genes linked to the ASD diagnosis to fall into the family of signaling pathways identified in Table 1 . We tested that hypothesis statistically against the Simons Foundation Autism Research Initiative (SFARI) Gene database. (9) The SFARI Gene is an evolving online database for the autism research community that is centered on genes implicated in autism susceptibility. Early inflammatory cytokine NLRP3
Inflammasome activated in ASD (22) Stress
CRH [5]
Corticotropin-releasing hormone, key hormone linking chronic stress with anxiety (23, 24) ; has direct effects on microglia (25) CRHR2 [5] Corticotropin-releasing hormone receptor 2; (25) HSD11B1 [4] 11β-Hydroxysteroid dehydrogenase type 1 (26) POMC Proopiomelanocortin (27) p-Akt Phosphorylated-Akt (28)
PI3K [S]
PI3K/Akt signaling pathway; e.g. PIK3CA (28,29)
OGT [5]
O-GlcNAc transferase; a placental biomarker of maternal stress exposure related to neurodevelopmental outcomes (30,31)
GAP43 [5]
Growth associated protein 43; in astrocytes, GAP43 mediates glial and neuronal plasticity during astrogliosis and attenuates microglial activation under LPS exposure (32)
SLC22A3 [5]
Solute carrier family 22 member 3; modulates anxiety and social interaction (33,34)
PLPPR4 [5]
Phospholipid Phosphatase Related 4; stress-related behaviors such as reduced resilience (35)
PRKCB [3]
Protein Kinase C Beta; involved in stress-related behavior (36)
UCN3 [5]
Urocortin 3; binds specifically CRHR2 (25)
DLG4 [5]
Disks large homolog 4; modulates stress reactivity and anxiety (37, 38) 
SLC25A39 [4]
Member of the SLC25 transporter or mitochondrial carrier family of proteins; required for normal heme biosynthesis Complement pathway
C1QA
Aside from its traditional role in innate immunity (44) , elements of the complement pathway are involved in neuronal-glial interactions; recognized as essential players in brain development, especially in synaptogenesis/synaptic pruning and predisposition for neurodegenerative diseases (8, 45) , their microglial expression is also susceptible to LPS exposure in utero (7) C1QB C (7) 3AR1 CR2
C4B [4]
Epigenetic memory
HDAC [S] and HAT families
Histone acetylation/deacetylation enzymes: HDAC 1, 2, 3, 7 and 9 found in SSC database of ASD gene mutations. HDAC 1, 2, 4 and 6 involved in fetal microglial memory of LPS exposure; HDAC 1, 2, 4 and 7 increased with altered neuronal AChE signaling and increased anxiety behavior due to adult chronic stress exposure (6, 7, 27, 29, 46, 47) Hits in the SFARI database (9) are in bold. ASD association score (48) indicated in square brackets: S: syndromic; 1: high confidence; 2: strong candidate; 3: suggestive evidence; 4: minimal evidence; 5: hypothesized; 6: not supported.
We used that database to identify genes with varying degrees of disruptive mutations associated with ASD as defined in the SFARI database to any of the genes in Table 1 . The analysis is based on accessing the database in August 2019 corresponding to the SFARI database update of June 20, 2019.
We identified 21 hits indicated in Table 1 in bold along with the level of confidence for association with ASD using the SFARI scoring criteria. (48) Scores denoted as S identified syndromic category and lower numbers in the range from 1 to 6 mean higher confidence in the association, 1 being the highest and 6 being the lowest. It is apparent that all categories defined in Table 1 are represented in the SFARI database: microglial or astrocytic phenotype, inflammation, stress, energy homeostasis, iron homeostasis, complement pathway, and epigenetic memory.
Next, we sought to validate the significance of the association of the identified genes using network analysis with string-db.org. The results can be accessed online at the permanent URL . They represent the analysis of the subset of 21 genes identified in Table 1 . While individually 16 out of the 21 identified genes were scored as weakly associated with ASD (scores 4 or 5 denoting minimal evidence or hypothesized), the network analysis shows a significant interaction between all 21 nods on the protein-protein interaction level with six network clusters shown in Figure 1 . These clusters form stress, metabolism, glia phenotype and epigenetic memory aspects of the proposed neuro-immunometabolic network exposed to stress or inflammation.
The data summarized in Figure 1 support our initial hypothesis linking both neuroinflammation and stress exposures in utero to etiology of ASD in a gene-environment paradigm: developmental combinations of genetic alterations in key pathways susceptible to environmental stimuli of inflammation or stress increase risk for or, perhaps, cause ASD. The clusters of interactions map onto the neuro-immunometabolic and stress response networks.
Current estimates suggest that variation in as many as 1,000 different genes could affect susceptibility to autism. In the attempt to tie this wealth of data together conceptually in a unified model, an endophenotype of autism has been proposed. (49) It is defined as a predictive impairment. Sinha et al. note in (49) that providing a cohesive conceptualization of ASD, such as the predictive impairment endophenotype, would ameliorate the search for broadly effective therapies, diagnostic markers, and neural/genetic correlates. Indeed, setting the ASD on the information theoretical platform in terms of prediction impairment reveals links to a major disruptor of the neural information processing -the stress. For example, the prediction impairment hypothesis interprets the reduced habituation and hence greater stress in ASD subjects as being caused by an endogenous predictive impairment which leads the environmental stimuli to appear more chaotic. By the same token, an autistic individual responds to the chaotic-appearing environment with endogenous mechanisms geared to reducing the chaos by exhibiting ritualized behaviors. These features of the proposed ASD endophenotype all have in common an attempt to reduce stress arising from increased uncertainty. Peters et al.
provide a neurobiological perspective on these psychological observations. (50) Their observations are based on the well-founded physical-mathematical concepts linking the energy expenditure, entropy and information processing, going back to Shannon and Boltzmann. (51, 52) This is combined with a body of neurobiological literature on the neuronal substrate of the brain's stress and prediction networks. (50) Herein, the so-called Selfish Bayesian Brain resolves stress, or information uncertainty, by an internal Baysian update of the knowledge state. This must take place at the expense of transiently increased energy needs (hence "selfish"). If this update succeeds, the stress is eustress; if it doesn't, it becomes a distress. The present findings suggest that one possible mechanism for when such an update can fail is when the increased energy needs cannot be met. We are proposing a developmental origins perspective on this framework. The neuro-immunometabolic and stress response networks interact and in utero exposure to stress or inflammation may alter the glial immunometabolic phenotype, i.e., the pattern of this network interaction. That consequence translates into less energy availability under the increased demands due to stress. (50) If the energy needs are not met, the allostatic load turns into an allostatic overload. (53) Neuropathology may ensure unless the situation is corrected.
We hope these data can be used in future in vivo studies to probe mechanistically for the role of these immunometabolic gene and protein networks in ASD etiology, in particular in the areas described as being the core of the prediction processing network, the anterior cingulate cortex. (54, 55) Indeed, a recent study reported that an immunometabolic dysregulation reduces the thickness of the anterior cingulate cortex. (56) The therapeutic approaches may include early postnatal reprogramming of the effects the intrauterine stress or inflammation exerted on brain development using behavioral (e.g., environmental enrichment) or bioelectronic tools. (57) In the context of the discussed neuro-immunometabolic and Selfish Bayesian Brain paradigms, environmental enrichment may help reduce the allostatic load by providing opportunities to perform the required knowledge state update in the face of existing uncertainties, i.e., stress.
Other salutary mechanisms mediating the therapeutic approaches may involve activation of the afferent cholinergic pathway. Vagal afferent signaling affects widely distributed areas of the brain via Nucleus tractus solitarii, and studies indicate that stimulation of the vagus nerve activates many neurons in both cerebral hemispheres and hippocampus. (58, 59) Vagal signaling in near-term fetus decreases HMGB1 concentrations in neuronal and astrocyte cytoplasm expressing α7nAChR and decreases microglial activation, which may decrease glial priming. (14) Hence, efferent peripheral or afferent vagal activity may mediate central neuroprotection via regulation of neuroinflammation. Vagus nerve stimulation has been shown to alter the phase synchrony in the anterior cingulate cortex improving decision making in rats. (60) The efferent wiring of the vagal cholinergic pathway has begun to unravel in the last decade, while our understanding of the afferent signaling is only beginning to emerge. The efferent component is also referred to as the inflammatory reflex which acts via the cholinergic anti-inflammatory pathway (CAP), a neural mechanism that influences the magnitude of innate immune responses to inflammatory stimuli and maintains homeostasis. (62) Through CAP, increased vagal activity inhibits the release of pro-inflammatory cytokines. We found that spontaneous CAP activity is present in the sheep fetus as early as at 0.76 gestation. (63) Moreover, CAP activation near-term suppresses activation of ovine microglia and astrocytes which express α7 nAChR or hypoxic-ischemic brain damage in newborn rats. (14, 19, (64) (65) (66) (67) Figure 1 . Gene network analysis of ASD associated genes driven by exposure to stress or inflammation followed by Markov Cluster Algorithm for unsupervised clustering identifies significant interactions between six clusters containing microglial and astrocytic phenotypes, inflammation, stress, energy (but not iron) homeostasis, and complement pathway. Note that stress pathways are represented in four clusters (yellow, green, aquamarine, dark cyan), while microglial phenotype, inflammation and complement pathway comprise one cluster (red). Protein-protein interaction (PPI) enrichment p-value: 0.00085. PPI legend by string-db.org (61) The detailed list of participating node members is provided in the Supplementary Table S1 .
In summary, these data suggest that early behavioral therapy or enhancing fetal CAP activity via vagal nerve stimulation or α7nAChR agonists will suppress the activation of microglia and astrocytes restoring their physiological immunometabolic phenotype, thus decreasing glial priming and preventing a sustained switch to a reactive phenotype. This approach might decrease the degree of brain injury sustained from fetal systemic and brain inflammatory responses and stress exposures, thus improving postnatal short-and long-term health outcomes, including susceptibility to ASD.
